Investigation of the antitumor potential of stimulator of interferon genes (STING) - an adaptor protein in innate immune signaling
2015/17/N/NZ6/04260
Keywords
Descriptors
- NZ6_1: Odporność swoista i nieswoista
- NZ5_7: Leczenie chorób człowieka
Panel
NZ6 – Human and animal immunology and infection: immunity, immune disorders, immunotherapy, infectious and invasive diseases, microbiology, transplantology, allergology
Host institution
Uniwersytet Warszawski, Centrum Nowych Technologii Uniwersytetu Warszawskiego
Voivodeship: mazowieckie
Principal investigator (from the host institution)
Number of co-investigators in the project: 3
Call
PRELUDIUM 9 – announced on 2015-03-16
- Amount awarded
- 97 800 PLN
- Project start date
- 2016-02-17
- Project end date
- 2018-02-16
- Project duration
- 24 months (the same as in the proposal)
- Project status
- Project settled
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
Publication in academic press/journals (2)
-
STING Signaling in Cancer Cells: Important or Not?
- Authors:
- Olga Sokołowska, Dominika Nowis
- Academic press:
- Archivum Immunologiae et Therapiae Experimentalis (year: 2018, volume: 66, pages: 125-132), Publisher: Springer
- Status:
- Published
- DOI:
- 10.1007/s00005-017-0481-7 – link to the publication
-
Immune checkpoint inhibition improves antimyeloma activity of bortezomib and STING agonist combination in Vk*MYC preclinical model
- Authors:
- Olga Sokolowska, Anna Rodziewicz-Lurzynska, Zofia Pilch, Hanna Kedzierska, Justyna Chlebowska-Tuz, Anna Sosnowska, Anna Szumera-Cieckiewicz, Kamil Sokol, Joanna Barankiewicz, Aleksander Salomon-Perzynski, Olga Ciepiela, Ewa Lech-Maranda, Jakub Golab, Dominika Nowis
- Status:
- Accepted for publication